In the U.S., outpatient imaging centres typically operate on tight budgets; the recent loss of revenue from decreased demand could lead toward more interest in value-priced solutions and retrofit equipment to manage capital outlay. A general trend toward floor-mounted systems, which are priced more cost-effectively than ceiling mounted systems could also be accelerated. With increased patient demand, our upside scenario would also see substantial investment in replacing aging radiography equipment in the outpatient setting for systems supporting higher patient throughput.
Conclusion
Although market predictions currently come with a higher than usual sense of uncertainty in the current climate, the mid-term outlook for general radiography and fluoroscopy market is still promising. General radiography equipment is one of the most used imaging modalities worldwide; with easing of pandemic measures expected over the next few months we are interpreting a broad market recovery in the next 2 years. However, with some leading emerging growth markets struggling to contain the pandemic and the threat of a “second wave” a possibility, several risks to market recovery still exist.
About the author: Imogen Fitt is a market analyst for Signify Research, an independent supplier of market intelligence and consultancy to the global healthcare technology industry. Signify's major coverage areas are Healthcare IT, Medical Imaging and Digital Health. Our clients include technology vendors, healthcare providers and payers, management consultants and investors. Signify Research is headquartered in Cranfield, U.K.Back to HCB News
